Immunomodulatory effect of stichopus japonicus acid mucopolysaccharide on experimental hepatocellular carcinoma in rats

Molecules

Volumn 18, Issue 6, 2013, Pages 7179-7193

  Song, Yang ^a   Jin, Shou Jie ^a   Cui, Lian Hua ^a   Ji, Xiao Jun ^a   Yang, Fu Guo ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Hepatocellular carcinoma; Macrophage; Natural killer cell; P21 expression; Proliferating cell nuclear antigen; Stichopus japonicus acid mucopolysaccharide; T lymphocyte subsets

Indexed keywords

BETA GLUCURONIDASE; CYCLINE; CYTOKINE; IMMUNOLOGIC FACTOR; LYASE; MUCOPOLYSACCHARIDASE; TUMOR MARKER;

ANIMAL; BIOPSY; BLOOD; BODY WEIGHT; CHEMISTRY; CYTOTOXICITY; DRUG EFFECTS; EXPERIMENTAL LIVER NEOPLASM; IMMUNOLOGY; IMMUNOMODULATION; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MACROPHAGE; MALE; METABOLISM; NATURAL KILLER CELL; PATHOLOGY; PHAGOCYTOSIS; RAT; SPLEEN; STICHOPUS; T LYMPHOCYTE SUBPOPULATION; THYMUS; TUMOR VOLUME; ARTICLE; DRUG EFFECT;

ANIMALS; BIOPSY; BODY WEIGHT; CARCINOMA, HEPATOCELLULAR; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GLUCURONIDASE; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; KILLER CELLS, NATURAL; LIVER; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; LYASES; MACROPHAGES; MALE; PHAGOCYTOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; SPLEEN; STICHOPUS; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84879672782     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18067179     Document Type: Article

References (35)

1. Gomaa, A.I.; Khan, S.A.; Toledano, M.B.; Waked, I.; Taylor-Robinson, S.D. Hepatocellular carcinoma: Epidemiology, Risk factors and pathogenesis. World J. Gastroenterol. 2008, 14, 4300-4308.
2. Yuan, H.; Song, J.; Li, X.; Li, N.; Dai, J. Immunomodulation and antitumor activity of kappa-carrageenan oligosaccharides. Cancer Lett. 2006, 243, 228-234.
3. Bordbar, S.; Anwar, F.; Saari, N. High-value components and bioactives from sea cucumbers for functional foods-a review. Mar. Drugs 2011, 9, 1761-1805.
4. Lu, Y.; Wang, B.L. The research progress of antitumorous effectiveness of Stichopus japonicus acid mucopolysaccharide in north of China. Am. J. Med. Sci. 2009, 337, 195-198.
5. Fan, H.Z. A new method for separation and purification of acidic mucopolysaccharide from stichopus japonicus. Zhong Yao Tong Bao 1982, 7, 27-29.
6. Kariya, Y.; Watabe, S.; Kyogashima, M.; Ishihara, M.; Ishii, T. Structure of fucose branches in the glycosaminoglycan from the body wall of the sea cucumber stichopus japonicus. Carbohydr. Res. 1997, 297, 273-279.
7. Lu, Y.; Zhang, B.Y.; Dong, Q.; Wang, B.L.; Sun, X.B. The effects of Stichopus japonicus acid mucopolysaccharide on the apoptosis of the human hepatocellular carcinoma cell line HepG2. Am. J. Med. Sci. 2010, 339, 141-144.
8. Fan, T.J.; Yuan, W.P.; Cong, R.S.; Yang, X.X.; Wang, W.W.; Jing, Z. Studies on the purification of water-soluble holothurian glycosides from Apostichpus japonicus and their tumor suppressing activity. Yao Xue Xue Bao 2009, 44, 25-31.
9. Budhu, A.; Forgues, M.; Ye, Q.H.; Jia, H.L.; He, P.; Zanetti, K.A.; Kammula, U.S.; Chen, Y.; Qin, L.X.; Tang, Z.Y.; et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a uique immune response signature of the liver microenvironment. Cancer Cell 2006, 10, 99-111.
10. Tsai, J.P.; Chen, H.W.; Cheng, M.L.; Liu, H.K.; Lee, Y.P.; Hsieh, C.L.; Luh, K.T.; Wu, C.W.; Hsu, L.H.; Chao, T.Y.; et al. Analysis of host versus tumor interaction in cancer patients: Opposing role of transforming growth factor-beta1 and interleu-kin-6 in the development of in situ tumor immunity. Immunobiology 2005, 210, 661-671.
11. Carl, J.W., Jr.; Liu, J.Q.; Joshi, P.S.; EI-Omrani, H.Y.; Yin, L.; Zheng, X.; Whitacre, C.C.; Liu, Y.; Bai, X.F. Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway. J. Immunol. 2008, 181, 320-328.
12. Mebius, R.E.; Kraal, G. Structure and function of the spleen. Nat. Rev. Immunol. 2005, 5, 606-616.
13. Liu, Y.; Jiao, F.; Qiu, Y.; Li, W.; Lao, F.; Zhou, G.; Sun, B.; Xing, G.; Dong, J.; Zhao, Y.; Chai, Z.; Chen, C. The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity. Biomaterials 2009, 30, 3934-3945.
14. Pardee, A.D.; Butterfield, L.H. Immunotherapy of Hepatocellular carcinoma: Unique challenges and clinical opportunities. Oncoimmunology 2012, 1, 48-55.
15. Grivennikov, S.I.; Greten, F.R.; Karin, M. Immunity, inflammation, and cancer. Cell 2010, 140, 833-899.
16. Haybaeck, J.; Zeller, N.; Wolf, M.J.; Weber, A.; Wagner, U.; Kurrer, M.O.; Bremer, J.; Iezzi, G.; Graf, R.; Clavien, P.A.; et al. A lymphotoxin-driven pathway to Hepatocellular carcinoma. Cancer Cell 2009, 16, 295-308.
17. Chen, G.G.; Lai, P.B.; Chak, E.C.; Xu, H.; Lee, K.M.; Lau, W.Y. Immunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastases. Cancer Lett. 2001, 172, 75-82.
18. Amin, A.; Hamza, A.A.; Bajbouj, K.; Ashraf, S.S.; Daoud, S. Saffron: A potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology 2011, 54, 857-867.
19. Rajewsky, M.F.; Dauber, W.; Frankenberg, H. Liver carcinogenesis by diethylnitrosamine in the rat. Science 1966, 152, 83-85.
20. Liu, J.G.; Zhao, H.J.; Liu, Y.J.; Liu, Y.W.; Wang, X.L. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats. J. Trace. Elem. Med. Biol. 2012, 26, 255-261.
21. Chakraborty, T.; Chatterjee, A.; Rana, A.; Srivastawa, S.; Damodaran, S.; Chatterjee M. Cell proliferation and hepatocarcinogenesis in rat initiated by diethynitrosamine and promoted by Phenobarbital: potential roles of early DNA damage and liver metallothionein expression. Life Sci. 2007, 81, 489-499.
22. Oyama, K.; Shiota, G.; Ito, H.; Murawaki, Y.; Kawasaki, H. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Carcinogenesis 2002, 23, 885-892.
23. Waga, S.; Hannon, G.J.; Beach, D.; Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994, 369, 574-578.
24. Oflazoglu, E.; Stone, I.J.; Gordon, K.A.; Grewal, I.S.; van, Rooijen, N.; Law, C.L.; Gerber, H.P. Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30. Blood 2007, 110, 4370-4372.
25. Kim, H.R.; Lee, K.H.; Park, S.J.; Kim S.Y.; Yang Y.K.; Tae, J.; Kim, J. Anti-cancer activity and mechanistic features of a NK cell activating molecule. Cancer Immunol. Immunother. 2009, 58, 1691-1700.
26. Zerbini, A.; Pilli, M.; Laccabue, D.; Pelosi, G.; Molinari, A.; Negri, E.; Cerioni, S.; Fagnoni, F.; Soliani, P.; Ferrari, C.; Missale, G. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response. Gastroenterology 2010, 138, 1931-1942.
27. Shavit, Y.; Ben-Eliyahu, S.; Zeidel, A.; Beilin, B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation 2004, 11, 255-260.
28. Wang, R.F.; Peng, G.; Wang, H.Y. Regulatory T cells and Toll-like receptors in tumor immunity. Semin. Immunol. 2006, 18, 136-142.
29. Nishimura, T.; Iwakabe, K.; Sekimoto, M.; Ohmi, Y.; Yahata, T.; Nakui, M.; Sato, T.; Habu, S.; Tashiro, H.; Sato, M.; et al. Distinct role of antigen-specific T helper type1 (Th1) and Th2 cells in tumor eradication in vivo. J. Exp. Med. 1999, 190, 617-627.
30. Grzywacz, B.; Dlubek, D.; Lange, A. NK cells become Ki-67+ in MLC and expend depending on the lack of ligand for KIR on stimulator cells in IL-2 supplemented MLC. Hum. Immunol. 2002, 63, 638-646.
31. Anderson, G.M.; Nakada, M.T.; DeWitte, M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr. Opin. Pharmacol. 2004, 4, 314-320.
32. Mocellin, S.; Rossi, C.R.; Pilati, P.; Nitti, D. Tumor necrosis factor, cancer and anticancer therpy. Cytokine Growth Factor Rev. 2005, 16, 35-53.
33. Chen, B; Ning, M.; Yang, G. Effect of paeonol on antioxidant and immune regulatory activity in Hepatocellular carcinoma rats. Molecules 2012, 17, 4672-4683.
34. Kotoh, T.; Dhar, D.K.; Masunga, R.; Tabara, H.; Tachibana, M.; Kubota, H.; Kohno, H.; Nagasue, N. Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice. Surgery 1999, 125, 536-544.
35. Amat, N.; Upur, H.; Ablimit, A.; Matsidik, A.; Yusup, A.; Kijjoa, A. Immunomodulatory effects of Abnormal Sava Munsiq, a traditional Uighur medicine, on the combined stress mice. J. Ethnopharmacol. 2009, 122, 42-47.